aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis]

RxCUI
1247397
RxNorm name
aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis]
Display name
BC ARTHRITIS (Oral Powder)
Full name
aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis]
Term type
SBD
Status
Active
Strength
1,000-65 mg
Dose form
Pwdr
Route
Oral Powder
Updated
2026-07-19 06:53:04

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042012
Active start
042012
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aspirin1000 MG / 1 EACHaspirinaspirin
caffeine65 MG / 1 EACHcaffeinecaffeine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Powder346289

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aspirin1191
caffeine1886

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis]NAMES
RxNorm Nameaspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis]NAMES
RxNorm SynonymASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis]NAMES
RxNorm SynonymBC Arthritis (ASA 1000 MG / caffeine 65 MG) Oral PowderNAMES
TTYSBDATTRIBUTES
SPL_SET_ID3a85be2d-6548-4de5-8109-60e1ca2bfca3CODES
RxCUI1247397CODES
MMSL_CODEBD27328CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
63029-990-0263029-990BC Arthritis Aspirin and CaffeineMedtech Products Inc.M013
63029-990-0663029-990BC Arthritis Aspirin and CaffeineMedtech Products Inc.M013
63029-990-5063029-990BC Arthritis Aspirin and CaffeineMedtech Products Inc.M013

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01363029-990BC Arthritis Aspirin and CaffeineOTC MONOGRAPH DRUGMedtech Products Inc.

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
42037010283rxnav_ndcsyes
42037010284rxnav_ndcsyes
42037011103rxnav_ndcsyes
63029020202rxnav_ndcsyes
63029020206rxnav_ndcsyes
63029099002rxnav_ndcsyes
63029099006rxnav_ndcsyes
63029099050rxnav_ndcsyes
00135050106rxnav_historical
00135050124rxnav_historical
00135050150rxnav_historical
10158000811rxnav_historical
10158000827rxnav_historical
10158001105rxnav_historical
63029020250rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
3a85be2d-6548-4de5-8109-60e1ca2bfca3BC Arthritis (ASA 1000 MG / caffeine 65 MG) Oral PowderSY3BC Arthritis - 63029-99020251023
3a85be2d-6548-4de5-8109-60e1ca2bfca3BC Arthritis 1000 MG / 65 MG Oral PowderPSN3BC Arthritis - 63029-99020251023
3a85be2d-6548-4de5-8109-60e1ca2bfca3aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis]SBD3BC Arthritis - 63029-99020251023
3a85be2d-6548-4de5-8109-60e1ca2bfca3ASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis]SY3BC Arthritis - 63029-99020251023

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
3a85be2d-6548-4de5-8109-60e1ca2bfca3BC Arthritis - 63029-990Medtech Products Inc.20251023
3a85be2d-6548-4de5-8109-60e1ca2bfca3BC Arthritis - 63029-990Medtech Products Inc.20241025

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA01ADOther agents for local oral treatmentATC1-4aspirin
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCB01ACPlatelet aggregation inhibitors excl. heparinATC1-4aspirin
ATCN02BASalicylic acid and derivativesATC1-4aspirin
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epcaspirin
FDASPLN0000175578Platelet Aggregation InhibitorEPChas_epcaspirin
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD001241AspirinCHEMhas_ingredientaspirin
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treataspirin
MEDRTD001778Blood Coagulation DisordersDISEASEci_withaspirin
MEDRTD001791Blood Platelet DisordersDISEASEci_withaspirin
MEDRTD002544Cerebral InfarctionDISEASEmay_preventaspirin
MEDRTD002644ChickenpoxDISEASEci_withaspirin
MEDRTD002675Child, PreschoolDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_treataspirin
MEDRTD006073GoutDISEASEmay_treataspirin
MEDRTD006396HematemesisDISEASEci_withaspirin
MEDRTD006474Hemorrhagic DisordersDISEASEci_withaspirin
MEDRTD007223InfantDISEASEci_withaspirin
MEDRTD007249InflammationDISEASEmay_treataspirin
MEDRTD002546Ischemic Attack, TransientDISEASEmay_preventaspirin
MEDRTD008551MelenaDISEASEci_withaspirin
MEDRTD009203Myocardial InfarctionDISEASEmay_preventaspirin
MEDRTD009298Nasal PolypsDISEASEci_withaspirin
MEDRTD010003OsteoarthritisDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_preventaspirin
MEDRTD010146PainDISEASEmay_treataspirin
MEDRTD011225Pre-EclampsiaDISEASEmay_preventaspirin
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withaspirin
MEDRTD012213Rheumatic FeverDISEASEmay_treataspirin
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaaspirin
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008831Decreased Platelet Activating Factor ProductionPEhas_peaspirin
MEDRTN0000008832Decreased Platelet AggregationPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peaspirin
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_peaspirin
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000000026Hepatic MetabolismPKhas_pkaspirin
MEDRTN0000000042Renal ExcretionPKhas_pkaspirin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH1000 MG / 65 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD27328
CODESRxCUI1247397
CODESSPL_SET_ID3a85be2d-6548-4de5-8109-60e1ca2bfca3
NAMESPrescribable SynonymBC Arthritis 1000 MG / 65 MG Oral Powder
NAMESRXNAV_STRASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis]
NAMESRxNorm Nameaspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis]
NAMESRxNorm SynonymASA 1000 MG / Caffeine 65 MG Oral Powder [BC Arthritis]
NAMESRxNorm SynonymBC Arthritis (ASA 1000 MG / caffeine 65 MG) Oral Powder
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon